Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Endeavouring the latest advancements in Neuroscience and Neurological Disorders

Andrea S. Bonzini

Neurological disorders have exaggerated lots of people universally ranging from epilepsy to Alzheimer disease, from stroke to headache. As appraised by WHO around 6.8 million people die each year due to these neurological disorders. The economic cost of neurological diseases was estimated at about 139 billion euros in 2004 in Europe.
The massive increase within the global marketplace for the neurological devices shows us the growing example of cerebral stroke, acute and chronic disorders like Epilepsy, Alzheimer’s, Parkinson’s, Huntington’s, Movement Disorders, Ataxia, Cerebrovascular disease, Multiple Sclerosis, etc…
It is estimated that 50 million U.S. people are affected by such neurological disorders which eventually lead to high expenditure treatment methods. The Transparency Market Research finds that it would reach a value of USD 13.6 billion in 2021 by the inspiring step which was available with a current report for neuroscience marketing device.